Advertisement
Screener

MOMENTA PHARMACEUTICALS INC Research and Development Expense

MOMENTA PHARMACEUTICALS INC Research and Development Expense

MOMENTA PHARMACEUTICALS INC reported Research and Development Expense of $38.84 million for the 3-month period ending 2020-06-30, per its 10-Q filed 2020-08-10.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2020-08-10

  • MOMENTA PHARMACEUTICALS INC research and development expense for the quarter ending 2020-06-30 was $38.84M, a 20.89% increase year-over-year.
  • MOMENTA PHARMACEUTICALS INC research and development expense for the quarter ending 2020-03-31 was $34.21M, a 22.29% increase year-over-year.
  • MOMENTA PHARMACEUTICALS INC research and development expense for the quarter ending 2019-12-31 was $38.33M, a 33.59% increase year-over-year.
  • MOMENTA PHARMACEUTICALS INC research and development expense for the quarter ending 2019-09-30 was $46.10M, a 50.05% increase year-over-year.
  • MOMENTA PHARMACEUTICALS INC research and development expense for fiscal 2019 was $144.54M, a 16.56% increase from fiscal 2018.
  • MOMENTA PHARMACEUTICALS INC research and development expense for fiscal 2018 was $124.00M, a 16.90% decline from fiscal 2017.
  • MOMENTA PHARMACEUTICALS INC research and development expense for fiscal 2017 was $149.23M, a 24.48% increase from fiscal 2016.
  • MOMENTA PHARMACEUTICALS INC research and development expense for fiscal 2016 was $119.88M, a 4.88% decline from fiscal 2015.
Period endResearch and Development Expense 3 monthResearch and Development Expense 6 monthResearch and Development Expense 9 monthResearch and Development Expense 12 month
2020-06-30$38.84M
10-Q · filed 2020-08-10
$73.05M
10-Q · filed 2020-08-10
$111.38M
derived: sum of 3 quarters · filed 2020-08-10
$157.49M
derived: sum of 4 quarters · filed 2020-08-10
2020-03-31$34.21M
10-Q · filed 2020-05-07
$72.54M
derived: sum of 2 quarters · filed 2020-05-07
$118.65M
derived: sum of 3 quarters · filed 2020-05-07
$150.78M
derived: sum of 4 quarters · filed 2020-08-10
2019-12-31$38.33M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$84.44M
derived: sum of 2 quarters · filed 2020-02-27
$116.57M
derived: sum of 3 quarters · filed 2020-08-10
$144.54M
10-K · filed 2020-02-27
2019-09-30$46.10M
10-Q · filed 2019-11-04
$78.24M
derived: sum of 2 quarters · filed 2020-08-10
$106.21M
10-Q · filed 2019-11-04
$134.90M
derived: sum of 4 quarters · filed 2020-08-10
2019-06-30$32.13M
10-Q · filed 2020-08-10
$60.10M
10-Q · filed 2020-08-10
$88.80M
derived: sum of 3 quarters · filed 2020-08-10
$119.53M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$27.97M
10-Q · filed 2020-05-07
$56.67M
derived: sum of 2 quarters · filed 2020-05-07
$87.39M
derived: sum of 3 quarters · filed 2020-05-07
$118.73M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31$28.70M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$59.42M
derived: sum of 2 quarters · filed 2020-02-27
$90.76M
derived: sum of 3 quarters · filed 2020-02-27
$124.00M
10-K · filed 2020-02-27
2018-09-30$30.73M
10-Q · filed 2019-11-04
$62.07M
derived: sum of 2 quarters · filed 2019-11-04
$95.31M
10-Q · filed 2019-11-04
$131.46M
derived: sum of 4 quarters · filed 2020-02-27
2018-06-30$31.34M
10-Q · filed 2019-08-07
$64.58M
10-Q · filed 2019-08-07
$100.73M
derived: sum of 3 quarters · filed 2020-02-27
$138.64M
derived: sum of 4 quarters · filed 2020-02-27
2018-03-31$33.24M
10-Q · filed 2019-05-03
$69.39M
derived: sum of 2 quarters · filed 2020-02-27
$107.30M
derived: sum of 3 quarters · filed 2020-02-27
$146.37M
derived: sum of 4 quarters · filed 2020-02-27
2017-12-31$36.15M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27
$74.06M
derived: sum of 2 quarters · filed 2020-02-27
$113.13M
derived: sum of 3 quarters · filed 2020-02-27
$149.23M
10-K · filed 2020-02-27
2017-09-30$37.91M
10-Q · filed 2018-11-07
$76.98M
derived: sum of 2 quarters · filed 2018-11-07
$113.08M
10-Q · filed 2018-11-07
$139.46M
derived: sum of 4 quarters · filed 2019-02-22
2017-06-30$39.06M
10-Q · filed 2018-08-09
$75.16M
10-Q · filed 2018-08-09
$101.55M
derived: sum of 3 quarters · filed 2019-02-22
$133.11M
derived: sum of 4 quarters · filed 2019-02-22
2017-03-31$36.10M
10-Q · filed 2018-05-09
$62.48M
derived: sum of 2 quarters · filed 2019-02-22
$94.05M
derived: sum of 3 quarters · filed 2019-02-22
$127.22M
derived: sum of 4 quarters · filed 2019-02-22
2016-12-31$26.38M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-22
$57.95M
derived: sum of 2 quarters · filed 2019-02-22
$91.12M
derived: sum of 3 quarters · filed 2019-02-22
$119.88M
10-K · filed 2019-02-22
2016-09-30$31.57M
10-Q · filed 2017-11-01
$64.74M
derived: sum of 2 quarters · filed 2017-11-01
$93.50M
10-Q · filed 2017-11-01
$131.06M
derived: sum of 4 quarters · filed 2018-02-26
2016-06-30$33.17M
10-Q · filed 2017-08-04
$61.93M
10-Q · filed 2017-08-04
$99.50M
derived: sum of 3 quarters · filed 2018-02-26
$131.23M
derived: sum of 4 quarters · filed 2018-02-26
2016-03-31$28.76M
10-Q · filed 2017-05-05
$66.32M
derived: sum of 2 quarters · filed 2018-02-26
$98.06M
derived: sum of 3 quarters · filed 2018-02-26
$132.04M
derived: sum of 4 quarters · filed 2018-02-26
2015-12-31$37.57M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-26
$69.30M
derived: sum of 2 quarters · filed 2018-02-26
$103.28M
derived: sum of 3 quarters · filed 2018-02-26
$126.03M
10-K · filed 2018-02-26
2015-09-30$31.73M
10-Q · filed 2016-11-04
$65.72M
derived: sum of 2 quarters · filed 2016-11-04
$88.47M
10-Q · filed 2016-11-04
$114.66M
derived: sum of 4 quarters · filed 2017-02-24
2015-06-30$33.98M
10-Q · filed 2016-08-05
$56.73M
10-Q · filed 2016-08-05
$82.92M
derived: sum of 3 quarters · filed 2017-02-24
$110.43M
derived: sum of 4 quarters · filed 2017-02-24
2015-03-31$22.75M
10-Q · filed 2016-05-06
$48.94M
derived: sum of 2 quarters · filed 2017-02-24
$76.45M
derived: sum of 3 quarters · filed 2017-02-24
$102.54M
derived: sum of 4 quarters · filed 2017-02-24
2014-12-31$26.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-24
$53.70M
derived: sum of 2 quarters · filed 2017-02-24
$79.79M
derived: sum of 3 quarters · filed 2017-02-24
$106.48M
10-K · filed 2017-02-24
2014-09-30$27.51M
10-Q · filed 2015-11-06
$53.60M
derived: sum of 2 quarters · filed 2015-11-06
$80.29M
10-Q · filed 2015-11-06
$112.52M
derived: sum of 4 quarters · filed 2016-02-26
2014-06-30$26.09M
10-Q · filed 2015-08-04
$52.78M
10-Q · filed 2015-08-04
$85.01M
derived: sum of 3 quarters · filed 2016-02-26
$112.44M
derived: sum of 4 quarters · filed 2016-02-26
2014-03-31$26.69M
10-Q · filed 2015-05-05
$58.92M
derived: sum of 2 quarters · filed 2016-02-26
$86.36M
derived: sum of 3 quarters · filed 2016-02-26
$108.35M
derived: sum of 4 quarters · filed 2016-02-26
2013-12-31$32.23M
derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-26
$59.66M
derived: sum of 2 quarters · filed 2016-02-26
$81.66M
derived: sum of 3 quarters · filed 2016-02-26
$104.00M
10-K · filed 2016-02-26
2013-09-30$27.43M
10-Q · filed 2014-11-07
$49.43M
derived: sum of 2 quarters · filed 2014-11-07
$71.77M
10-Q · filed 2014-11-07
$93.30M
derived: sum of 4 quarters · filed 2015-02-27
2013-06-30$21.99M
10-Q · filed 2014-08-04
$44.33M
10-Q · filed 2014-08-04
$65.87M
derived: sum of 3 quarters · filed 2015-02-27
$86.10M
derived: sum of 4 quarters · filed 2015-02-27
2013-03-31$22.33M
10-Q · filed 2014-05-06
$43.87M
derived: sum of 2 quarters · filed 2015-02-27
$64.11M
derived: sum of 3 quarters · filed 2015-02-27
$84.12M
derived: sum of 4 quarters · filed 2015-02-27
2012-12-31$21.54M
derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-27
$41.77M
derived: sum of 2 quarters · filed 2015-02-27
$61.78M
derived: sum of 3 quarters · filed 2015-02-27
$80.34M
10-K · filed 2015-02-27
2012-09-30$20.23M
10-Q · filed 2013-11-08
$40.24M
derived: sum of 2 quarters · filed 2013-11-08
$58.80M
10-Q · filed 2013-11-08
$80.05M
derived: sum of 4 quarters · filed 2014-02-28
2012-06-30$20.01M
10-Q · filed 2013-08-06
$38.57M
10-Q · filed 2013-08-06
$59.81M
derived: sum of 3 quarters · filed 2014-02-28
$76.12M
derived: sum of 4 quarters · filed 2014-02-28
2012-03-31$18.56M
10-Q · filed 2013-05-10
$39.80M
derived: sum of 2 quarters · filed 2014-02-28
$56.11M
derived: sum of 3 quarters · filed 2014-02-28
$70.28M
derived: sum of 4 quarters · filed 2014-02-28
2011-12-31$21.24M
derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-28
$37.55M
derived: sum of 2 quarters · filed 2014-02-28
$51.71M
derived: sum of 3 quarters · filed 2014-02-28
$64.66M
10-K · filed 2014-02-28
2011-09-30$16.31M
10-Q · filed 2012-11-08
$30.48M
derived: sum of 2 quarters · filed 2012-11-08
$43.42M
10-Q · filed 2012-11-08
$58.61M
derived: sum of 4 quarters · filed 2013-02-28
2011-06-30$14.17M
10-Q · filed 2012-08-08
$27.11M
10-Q · filed 2012-08-08
$42.30M
derived: sum of 3 quarters · filed 2013-02-28
$54.79M
derived: sum of 4 quarters · filed 2013-02-28
2011-03-31$12.94M
10-Q · filed 2012-05-09
$28.13M
derived: sum of 2 quarters · filed 2013-02-28
$40.62M
derived: sum of 3 quarters · filed 2013-02-28
$52.40M
derived: sum of 4 quarters · filed 2013-02-28
2010-12-31$15.19M
derived: 10-K 12 month − 10-Q 9 month · filed 2013-02-28
$27.68M
derived: sum of 2 quarters · filed 2013-02-28
$39.46M
derived: sum of 3 quarters · filed 2013-02-28
$51.71M
10-K · filed 2013-02-28
2010-09-30$12.49M
10-Q · filed 2011-11-08
$24.27M
derived: sum of 2 quarters · filed 2011-11-08
$36.52M
10-Q · filed 2011-11-08
2010-06-30$11.78M
10-Q · filed 2011-08-05
$24.03M
10-Q · filed 2011-08-05
2009-12-31$60.61M
10-K · filed 2012-02-28